BAX DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX
08 sept. 2023 21h12 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 25, 2022...
ROSEN, A LEADING LAW FIRM, Encourages Baxter International Inc. Investors With Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX
03 sept. 2023 11h31 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 03, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
28 août 2023 20h27 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022 and...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
23 août 2023 19h08 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX
13 août 2023 08h52 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 13, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
08 août 2023 13h33 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
28 juil. 2023 20h59 HE
|
The Rosen Law Firm PA
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
23 juil. 2023 12h06 HE
|
The Rosen Law Firm PA
NEW YORK, July 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022 and...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
17 juil. 2023 20h00 HE
|
The Rosen Law Firm PA
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Baxter...
Corbus Pharmaceuticals Appoints Rachelle Jacques to Board of Directors
08 avr. 2019 08h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
Appointment brings global commercialization and marketing experience for rare diseases to the Board of Directors Appointment aligns with Company’s vision to become the leader in the treatment of...